Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Woongyang Park"'
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 11, Iss Suppl 1 (2023)
Externí odkaz:
https://doaj.org/article/7fb4189bb62a45108026082676941a56
Publikováno v:
Precision and Future Medicine, Vol 1, Iss 1, Pp 52-57 (2017)
Hidradenocarcinoma is an extremely rare cutaneous skin carcinoma which arise from the sweat gland. There are several report about potential targets in this rare disease including estrogen receptor (ER) and human epidermal growth factor receptor 2 (HE
Externí odkaz:
https://doaj.org/article/779a38c9d1954d91839628ca88faa842
Autor:
Hee Kyung Kim, Sunyoung Lee, Kyung Kim, Mi Hwa Heo, Hansang Lee, Jinhyun Cho, Nayoung K.D. Kim, Woongyang Park, Su Jin Lee, Jung Han Kim, Kee-Taek Jang, Sang-Hee Choi, Jeeyun Lee
Publikováno v:
Translational Oncology, Vol 9, Iss 6, Pp 557-564 (2016)
BACKGROUND: The BRAF inhibitors vemurafenib and dabrafenib are currently the standard treatment for metastatic melanoma with BRAF V600 mutations. However, given the rarity of noncutaneous melanoma, including acral and mucosal subtypes, the efficacy o
Externí odkaz:
https://doaj.org/article/7f9a4d0d053c4fae907f62e9a4bf009d
Autor:
Jun Soo Ham, Seokhwi Kim, Hee Kyung Kim, Seonggyu Byeon, Jong-Mu Sun, Se-hoon Lee, Jin Seok Ahn, Keunchil Park, Yoon-La Choi, Joungho Han, Woongyang Park, Myung-Ju Ahn, Ham, Jun Soo, Kim, Seokhwi, Kim, Hee Kyung, Byeon, Seonggyu, Sun, Jong-Mu, Lee, Se-Hoon, Ahn, Jin Seok, Park, Keunchil
Publikováno v:
Journal of Thoracic Oncology; Jan2016, Vol. 11 Issue 1, pe1-e4, 4p